Uncategorized

New Releases from NCBI BookshelfMethods and mechanisms for measuring and monitoring outcomes from newborn bloodspot screening: a scoping review.Methods and mechanisms for measuring and monitoring outcomes from newborn bloodspot screening: a scoping review.

Newborn bloodspot screening offers the potential to detect rare diseases early, enabling timely treatment that can reduce mortality and morbidity. […]

Uncategorized

New Releases from NCBI BookshelfCare of dying adults in the last days of life.Care of dying adults in the last days of life.

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfQuizartinib (Vanflyta): Therapeutic area: Acute myeloid leukemia: Reimbursement Review [Internet].Quizartinib (Vanflyta): Therapeutic area: Acute myeloid leukemia: Reimbursement Review [Internet].

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfIbrutinib: Reimbursement Recommendation [Internet].Ibrutinib: Reimbursement Recommendation [Internet].

Leave a Comment / Uncategorized / admin

The Formulary Management Expert Committee (FMEC) recommends that ibrutinib in combination with immunochemotherapy with or without autologous stem cell transplant

Uncategorized

New Releases from NCBI BookshelfVorasidenib (Voranigo): Indication: For the treatment of Grade 2 (World Health Organization [WHO] 2016, 2021 grading system) astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation or isocitrate dehydrogenase-2 (IDH2) mutation in adults and pediatric patients aged 12 years and older following surgical intervention: Reimbursement Recommendation [Internet].Vorasidenib (Voranigo): Indication: For the treatment of Grade 2 (World Health Organization [WHO] 2016, 2021 grading system) astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation or isocitrate dehydrogenase-2 (IDH2) mutation in adults and pediatric patients aged 12 years and older following surgical intervention: Reimbursement Recommendation [Internet].

Leave a Comment / Uncategorized / admin

Canada’s Drug Agency (CDA-AMC) recommends that Voranigo be reimbursed by public drug plans for patients aged 12 years and older

Uncategorized

New Releases from NCBI BookshelfChildren’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care.Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care.

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfFederal Policies and Public Reimbursement of Pediatric Medicines in Canada: Drugs, Health Systems [Internet].Federal Policies and Public Reimbursement of Pediatric Medicines in Canada: Drugs, Health Systems [Internet].

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfBlood transfusion.Blood transfusion.

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfModels of perinatal care for women using drugs and their infants: synopsis of The Stepping Stones Study.Models of perinatal care for women using drugs and their infants: synopsis of The Stepping Stones Study.

Leave a Comment / Uncategorized / admin

Women who use drugs during the perinatal period often have complex health and social care needs. Their infants can experience

Uncategorized

New Releases from NCBI BookshelfEffectiveness, safety and cost-effectiveness of methotrexate versus ciclosporin for severe childhood atopic dermatitis: a synopsis of the TREAT RCT.Effectiveness, safety and cost-effectiveness of methotrexate versus ciclosporin for severe childhood atopic dermatitis: a synopsis of the TREAT RCT.

Leave a Comment / Uncategorized / admin

Parts of this abstract have been reproduced from Flohr C, Rosala-Hallas A, Jones AP, Beattie P, Baron S, Browne F,

New Releases from NCBI BookshelfMethods and mechanisms for measuring and monitoring outcomes from newborn bloodspot screening: a scoping review.Methods and mechanisms for measuring and monitoring outcomes from newborn bloodspot screening: a scoping review.

New Releases from NCBI BookshelfCare of dying adults in the last days of life.Care of dying adults in the last days of life.

New Releases from NCBI BookshelfQuizartinib (Vanflyta): Therapeutic area: Acute myeloid leukemia: Reimbursement Review [Internet].Quizartinib (Vanflyta): Therapeutic area: Acute myeloid leukemia: Reimbursement Review [Internet].

New Releases from NCBI BookshelfIbrutinib: Reimbursement Recommendation [Internet].Ibrutinib: Reimbursement Recommendation [Internet].

New Releases from NCBI BookshelfFederal Policies and Public Reimbursement of Pediatric Medicines in Canada: Drugs, Health Systems [Internet].Federal Policies and Public Reimbursement of Pediatric Medicines in Canada: Drugs, Health Systems [Internet].

New Releases from NCBI BookshelfBlood transfusion.Blood transfusion.

New Releases from NCBI BookshelfModels of perinatal care for women using drugs and their infants: synopsis of The Stepping Stones Study.Models of perinatal care for women using drugs and their infants: synopsis of The Stepping Stones Study.

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.